Senior Director, Global Commercial Strategy, Lymphoma

Join to apply for the

Senior Director, Global Commercial Strategy, Lymphoma

role at

Kite Pharma

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T‑cell therapies have changed the paradigm. But we’re not finished yet.

Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.

Job Description

Senior Director, Global Commercial Strategy, Lymphoma

This role will be pivotal in shaping the future of cell therapy in lymphoma, driving the development and execution of brand strategy, launch plans, and tactical initiatives for new and in‑line products. The Senior Director will serve as the marketing product team member for the NextGen Lymphoma Product Team (PT) and lead the Global Commercial Strategy (GCS) Lymphoma team. This high‑impact, high‑visibility position offers a unique opportunity to influence Kite’s approach in a therapeutic area of strategic importance, collaborating closely with internal teams and external partners to maximize brand value and patient impact worldwide.

Key Responsibilities

Lead the development of the Lymphoma Integrated Strategic Planning (ISP) and the associated Plan of Action, working in close collaboration with all the functions

Serve as the marketing product team member (PTM) for the NextGen Lymphoma Product Team (PT), bringing the voice of the customer into the development plan.

Lead the GCS Lymphoma team, providing strategic direction and oversight to the Yescarta & Tecartus Global Commercial Strategy Director and the Lymphoma Global Commercial Strategy Senior Manager / Associate Director.

Co‑lead the Lymphoma Global Brand Team in partnership with the Global Medical Affairs and Value & Access lead for Lymphoma driving cross‑functional alignment to ensure cohesive strategy and tactic execution.

Act as the brand champion for Lymphoma NextGen Asset, collaborating with internal and external stakeholders to ensure optimal global commercialization.

Analyze the lymphoma disease landscape and competitive environment, distilling insights to support a differentiated brand strategy.

Develop and nurture collaborations that drive business objectives, including partnerships with global regions and external organizations.

Lead the development of global strategic launch plans for Kite’s Lymphoma NextGen Asset, maximizing brand value at launch and supporting long‑term performance.

Basic Qualifications

Ph.D. and 7 Years’ Experience OR

Master’s Degree and 10 Years’ Experience OR

Bachelor’s Degree and 12 Years’ Experience

Preferred Qualifications

Proven experience in pharmaceutical global strategic marketing, with a focus on commercial partnerships and product launches in hematology and / or cell therapy

Experience executing key brand deliverables at country or regional level.

Strong leadership skills within large, matrixed organizations; ability to navigate complex business structures.

Resilient profile with the ability to deliver in an ambiguous environment and complex matrix.

Ability to collaborate effectively with cross‑functional partners (clinical, medical, tech‑ops, regulatory, etc.) to shape program strategy.

Experience in hematology and in the lymphoma space is highly desirable.

Approachable and credible communication style, both verbally and written, to keep all levels of the organization informed and engaged.

Ability to engage and manage multiple stakeholders, including senior executives.

Curious, with learning agility and a drive for excellence and high‑quality deliverables.

Organized with a systematic approach to prioritization.

Role model of Kite / Gilead core values, inspiring a high‑performance culture and engagement.

Strategic Priorities & Context

Advance next‑generation outpatient enabling assets to replace or complement Yescarta & Tecartus.

Achieve global revenue and patient delivery targets for Yescarta & Tecartus.

Expand access for CAR T globally and establish best‑in‑class therapies in competitive environments.

The salary range for this position is : $237,575.00 - $307,450.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock‑based long‑term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company‑sponsored medical, dental, vision, and life insurance plans

For additional benefits information, visit https : / / www.gilead.com / careers / compensation-benefits-and-wellbeing.

Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

Kite Pharma is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status or other non‑job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.

For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.

NOTICE : EMPLOYEE POLYGRAPH PROTECTION ACT

YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Kite Pharma will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Kite Pharma provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

#J-18808-Ljbffr